# Efficacy and Safety of Bivalirudin Versus Heparin During Coil Embolization in Patients With Ruptured Intracranial Aneurysms

> **NCT04532333** · PHASE3 · UNKNOWN · sponsor: **Changhai Hospital** · enrollment: 236 (estimated)

## Conditions studied

- Subarachnoid Hemorrhage, Aneurysmal

## Interventions

- **DRUG:** Bivalirudin 250 MG Injection
- **DRUG:** Heparin

## Key facts

- **NCT ID:** NCT04532333
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-08
- **Primary completion:** 2021-05
- **Final completion:** 2021-06
- **Target enrollment:** 236 (ESTIMATED)
- **Last updated:** 2020-08-31

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04532333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04532333, "Efficacy and Safety of Bivalirudin Versus Heparin During Coil Embolization in Patients With Ruptured Intracranial Aneurysms". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04532333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*